Fund+
Overview
Fund+ is an open-ended Fund for long term equity investment in innovative Life Sciences companies with a focus on Belgium. It aims to create sustainable shareholders value, contribute to the development of a leadership position in the Life Sciences sector and generate a tangible, beneficial societal impact.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AstriVax | Aug 2022 | Seed | Lead |
| ExeVir Bio | Mar 2021 | Series A | Lead |
| Promethera Biosciences | Jun 2021 | Corporate Funding | Co-investor |
| eTheRNA | Aug 2022 | Series B Extension | Co-investor |
| Indigo Diabetes N.V. | Jul 2020 | Series B | Lead |
For institutional investors. Book with your work email.
Key People
Halina Novak
Associate Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Fund+ based?
Fund+ is headquartered in Leuven, Flanders, Belgium.
When was Fund+ founded?
Fund+ was founded in 2015.
How many portfolio companies does Fund+ have?
Fund+ has 17 portfolio companies in Caplight's dataset.
What are some companies in Fund+'s portfolio?
Portfolio companies visible on Caplight include AstriVax, ExeVir Bio, Promethera Biosciences, eTheRNA, Indigo Diabetes N.V..
What was Fund+'s most recent investment shown here?
Fund+'s most recent investment in this portfolio sample was in AstriVax in 2022.
What sectors does Fund+ focus on?
Fund+ focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Fund+ focus on?
Fund+ typically invests at the Early stage.
What is Fund+'s AUM?
Fund+'s assets under management are estimated between $250.0M and $500.0M.